Literature DB >> 23247862

Surgical treatment of cauda equina compression as a result of metastatic tumours of the lumbo-sacral junction and sacrum.

Nasir A Quraishi1, K E Giannoulis, S R Manoharan, K L Edwards, B M Boszczyk.   

Abstract

PURPOSE: We performed a retrospective analysis of all cases of lumbo-sacral or sacral metastases presenting with compression of the cauda equina who underwent urgent surgery at our institution. Our objective was to report our experience on the clinical presentation, management and finally the surgical outcome of this cohort of patients.
METHODS: We reviewed medical notes and images of all patients with compression of the cauda equina as a result of lumbo-sacral or sacral metastases during the study period (2004-2011). The collected clinical data consisted of time of onset of symptoms, neurology (Frankel grade), ambulatory status and continence. Operative data analysed were details of surgical procedure and complications. Post-operatively, we reviewed neurological outcome, ambulation, continence, destination of discharge and survival.
RESULTS: During the 8-year study period, 20 patients [11 males, 9 females; mean age 61.8 years (29-87)] had received urgent surgery for metastatic spinal cauda compression caused by lumbo-sacral or sacral metastases. The majority of patients presented with symptoms of pain and neurological deterioration (n = 14) with onset of pain considerably longer than neurology symptoms [197 days (3-1,825) vs. 46 days (1-540)]; all patients were Frankel C (n = 2, both non-ambulatory), D (n = 13) or E (n = 5) at presentation and three patients were incontinent of urine. Operative procedures performed were posterior decompression with (out) fusion (n = 12), posterior decompression with sacroplasty (n = 1), decompression with lumbo-pelvic stabilisation with (out) kyphoplasty/sacroplasty (n = 7) and posterior decompression/reconstruction with anterior corpectomy/stabilisation (n = 2). Post-operatively, 5/20 (20 %) patients improved one Frankel grade, 1/20 (5 %) improved two grades, 13/20 (65 %) remained stable (8 D, 5 E) and 1/20 (5 %) deteriorated. All patients were ambulatory and 19/20 were continent on discharge. The mean length of stay was 7 days (4-22). There were 6/20 (30 %) complications: three major (PE, deep wound infection, implant failure) and three minor (superficial wound infection, incidental durotomy, chest infection). All patients returned back to their own home (n = 14/20, 70 %) or a nursing home (n = 6/20, 35 %). Thirteen patients are deceased (mean survival 367 days (120-603) and seven are still alive [mean survival 719 days (160-1,719)].
CONCLUSION: Surgical intervention for MSCC involving the lumbo-sacral junction or sacral spine has a high but acceptable complication rate (6/20, 30 %), and can be important in restoring/preserving neurological function, assisting with ambulatory function and allowing patients to return to their previous residence.

Entities:  

Mesh:

Year:  2012        PMID: 23247862      PMCID: PMC3578512          DOI: 10.1007/s00586-012-2615-2

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  21 in total

1.  Treatment of neoplastic diseases of the sacrum.

Authors:  G H Raque; T W Vitaz; C B Shields
Journal:  J Surg Oncol       Date:  2001-04       Impact factor: 3.454

2.  Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention.

Authors:  Y Kollender; J Bickels; W M Price; K L Kellar; J Chen; O Merimsky; I Meller; M M Malawer
Journal:  J Urol       Date:  2000-11       Impact factor: 7.450

3.  Neural function preservation and early mobilization after resection of metastatic sacral tumors and lumbosacropelvic junction reconstruction. Report of three cases.

Authors:  Sean A Salehi; Randall R McCafferty; Dean Karahalios; Stephen L Ondra
Journal:  J Neurosurg       Date:  2002-07       Impact factor: 5.115

Review 4.  Management of metastatic sacral tumours.

Authors:  Nasir A Quraishi; Kyriakos E Giannoulis; Kimberley L Edwards; Bronek M Boszczyk
Journal:  Eur Spine J       Date:  2012-06-23       Impact factor: 3.134

5.  Combined therapy for metastatic extradural tumors of the spine.

Authors:  L F Marshall; T W Langfitt
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

6.  Chordoma. Thirty-five-year study at Memorial Hospital.

Authors:  N L Higinbotham; R F Phillips; H W Farr; H O Hustu
Journal:  Cancer       Date:  1967-11       Impact factor: 6.860

7.  Surgical management of symptomatic spinal metastases. Postoperative outcome and quality of life.

Authors:  B Weigel; M Maghsudi; C Neumann; R Kretschmer; F J Müller; M Nerlich
Journal:  Spine (Phila Pa 1976)       Date:  1999-11-01       Impact factor: 3.468

8.  Total sacrectomy and reconstruction: oncologic and functional outcome.

Authors:  P Wuisman; O Lieshout; S Sugihara; M van Dijk
Journal:  Clin Orthop Relat Res       Date:  2000-12       Impact factor: 4.176

Review 9.  Radiosurgery and radiotherapy for sacral tumors.

Authors:  Iris C Gibbs; Steven D Chang
Journal:  Neurosurg Focus       Date:  2003-08-15       Impact factor: 4.047

10.  Role of adjuvant cryosurgery in intralesional treatment of sacral tumors.

Authors:  Yehuda Kollender; Issac Meller; Jacob Bickels; Gideon Flusser; Josefin Issakov; Ofer Merimsky; Nissim Marouani; Alexander Nirkin; Avi A Weinbroum
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

View more
  1 in total

Review 1.  The Challenges of Renal Cell Carcinoma Metastatic to the Spine: A Systematic Review of Survival and Treatment.

Authors:  C Rory Goodwin; A Karim Ahmed; Christine Boone; Nancy Abu-Bonsrah; Risheng Xu; Niccole Germscheid; Daryl R Fourney; Michelle Clarke; Ilya Laufer; Charles G Fisher; Chetan Bettegowda; Daniel M Sciubba
Journal:  Global Spine J       Date:  2017-11-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.